London, 21 September 2015 – Technavio has published a new report on the global oncology molecular diagnostics market, which is expected to grow at a CAGR of nearly 18% from 2015-2019.
About the Report
The latest report by Technavio indicates the development of personalized drugs, which is based on the identification and study of protein and gene expressions. Proteins and genes control the biochemical functions of the body, hence these drugs are customized to an individual’s protein or genetic profiles.
“A lot of pharmaceutical companies are now developing personalized medicines to provide better patient management, which is a trend expected to boost market growth in the forecast period,” says Faisal Ghaus, Vice President of Technavio.
The latest report by Technavio also emphasizes mass spectrometry technology that can provide accurate results from small amounts of biological material and does not require specially purified samples, which may soon be used for diagnostic purposes in complex surgeries.
“In the coming years, mass spectrometry technology will produce breakthrough advances by characterizing macromolecules during diagnosis and determining therapy for patients who do not respond to many treatments,” adds Ghaus.
Market Scope and Calculation of Market Size
The new Technavio report covers the present scenario and growth prospects of the global oncology molecular diagnostics market from 2015-2019. To calculate the market size, we use revenue generated from the sales of molecular diagnostic products for breast cancer, colorectal cancer, prostate cancer, and other cancers.
Key Information Covered in the Report:
Key Vendors:
- Abbott Diagnostics
- Becton, Dickinson
- Qiagen
- Roche Diagnostics
Market Growth Drivers:
- High demand for personalized medicines
- For a full detailed list, view our report.
Market Challenges:
- Ethical, privacy, and practical issues
- For a full detailed list, view our report.
Market Trends:
- Advances in mass spectrometry
- For a full detailed list, view our report.
https://www.technavio.com/%3Cp%3E%3Cstrong%3E%3Ca%20href%3D%22http%3A//ww…
